Karl Ziegelbauer

Dr. Ziegelbauer holds a PhD in Biochemistry from the University of Tübingen (Germany). Before joining Almirall, he served as Senior Vice President and Head of Open Innovation & Digital Technologies at Bayer Pharmaceuticals. Dr. Ziegelbauer has three decades of experience in drug discovery in international markets such as Germany, Japan, and the United States. He has developed most of his career at the German multinational pharmaceutical company and has assumed positions of increasing responsibility, holding Senior Vice President roles in various medical research fields. Dr. Ziegelbauer has also co-authored more than 50 scientific publications covering basic research as well as drug discovery topics.